IPP Bureau

Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran
Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran

By IPP Bureau - September 11, 2023

Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension

Briefs: NATCO Pharma, Strides Pharma and Aurobindo Pharma
Briefs: NATCO Pharma, Strides Pharma and Aurobindo Pharma

By IPP Bureau - September 08, 2023

Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.

Apollo Hospitals launches the latest generation ophthalmology laser machine, FEMTO LDV Z8 from Ziemer
Apollo Hospitals launches the latest generation ophthalmology laser machine, FEMTO LDV Z8 from Ziemer

By IPP Bureau - September 08, 2023

Kiran Mazumdar-Shaw appointed as member of the Court of Regents at the Royal College of Surgeons of Edinburgh
Kiran Mazumdar-Shaw appointed as member of the Court of Regents at the Royal College of Surgeons of Edinburgh

By IPP Bureau - September 08, 2023

The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field

Fermenta Biotech inaugurates customized premix manufacturing plant in Kullu, Himachal Pradesh
Fermenta Biotech inaugurates customized premix manufacturing plant in Kullu, Himachal Pradesh

By IPP Bureau - September 08, 2023

The company will develop and produce premixes for human nutrition applications

Kokilaben Dhirubhai Ambani Hospital luanches India's first of its kind advanced Digital PET-CT scanner
Kokilaben Dhirubhai Ambani Hospital luanches India's first of its kind advanced Digital PET-CT scanner

By IPP Bureau - September 08, 2023

The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services

Takeda emphasizes DEI to bring equal opportunities for all at the G20 Summit
Takeda emphasizes DEI to bring equal opportunities for all at the G20 Summit

By IPP Bureau - September 08, 2023

The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit

Sodexo launches patient nutrition solution 'Aarogyum’
Sodexo launches patient nutrition solution 'Aarogyum’

By IPP Bureau - September 08, 2023

With All India Institute of Ayurveda as a knowledge partner and Sodexo’s culinary expertise, Aarogyum is a well-rounded offering in patient dining solutions

Gautam Solar donates medical equipment to AIIMS Delhi burns ward
Gautam Solar donates medical equipment to AIIMS Delhi burns ward

By IPP Bureau - September 08, 2023

The generous donation includes multiple medical equipments

Pachouli Aesthetics & Wellness launches its Faridabad Clinic
Pachouli Aesthetics & Wellness launches its Faridabad Clinic

By IPP Bureau - September 08, 2023

Marking a significant milestone in its commitment to holistic wellness

Biocon Biologics completes integration of Viatris Biosimilars’ business in North America
Biocon Biologics completes integration of Viatris Biosimilars’ business in North America

By IPP Bureau - September 07, 2023

Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris

NTPC partners with Apollo Hospitals to introduce Tele-Emergency and Tele-ICU Services across its 9 plants locations
NTPC partners with Apollo Hospitals to introduce Tele-Emergency and Tele-ICU Services across its 9 plants locations

By IPP Bureau - September 07, 2023

These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda

Aptar appoints Sarah Glickman to its Board of Directors
Aptar appoints Sarah Glickman to its Board of Directors

By IPP Bureau - September 07, 2023

Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.

Apollo Hospitals joins MediSage to host Uro-Oncology symposium
Apollo Hospitals joins MediSage to host Uro-Oncology symposium

By IPP Bureau - September 07, 2023

Our collaboration with MediSage to present 'Current Approaches to Uro-Oncology' embodies a crucial stride towards comprehensive cancer care

Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients
Lupin, Cost Plus Drug and COPD Foundation to expand access to medication for COPD patients

By IPP Bureau - September 07, 2023

This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US

Latest Stories

Interviews

Packaging